Table 3.
Sensitivity of COV2T and COV2G Tests Calculated Against Day of Positive PCR Result and Day of Symptom Onset
| Days After PCR Positivity | Days After Symptom Onset | |||
|---|---|---|---|---|
| COV2T | COV2G | COV2T | COV2G | |
| < 4 d | 25.0% (10/40; 12.7–41.2) | 17.5% (7/40; 7.3–32.8) | 5.9% (1/17; 0.2–28.7) | 5.9% (1/17; 0.2–28.7) |
| 4–7 d | 39.0% (16/41; 24.2–55.5) | 31.7% (13/41; 18.1–48.1) | 19.4% (6/31; 7.5–37.5) | 12.9% (4/31; 3.63–29.8) |
| 8–10 d | 62.1% (18/29; 42.3–79.3) | 44.8% (13/29; 26.5–64.3) | 57.1% (12/21; 34.0–78.2) | 38.1% (8/21; 18.1–61.6) |
| 11–14 d | 90.3% (28/31; 74.3–98.0) | 64.5% (20/31; 45.4–80.8) | 84.4% (27/32; 67.2–94.7) | 56.3% (18/32; 37.7–73.6) |
| > 14 d | 100.0% (34/34; 89.7–100.0) | 97.1% (33/34; 84.7–100.0) | 92.9% (53/56; 85.1–98.9) | 91.1% (51/56; 80.4–97.0) |
COV2T, SARS-CoV-2 Total antibody assay; COV2G, SARS-CoV-2 IgG antibody assay; PCR, polymerase chain reaction.
Numbers in parentheses are absolute specimen numbers, followed by calculated 95% confidence intervals for sensitivity.